Valuation: Embracing Future Holdings Limited

Market Cap 31.2M 24.24M 21.92M 20.24M 18.32M 34.57M 2.28B 35.6M 243M 96.53M 1.22B 90.99M 89.05M 3.88B P/E 2024
-8.18x
P/E 2025 -22.5x
Enterprise Value 33.06M 25.69M 23.23M 21.44M 19.41M 36.62M 2.41B 37.72M 257M 102M 1.29B 96.4M 94.35M 4.11B EV / Sales 2024
58.8x
EV / Sales 2025 17.5x
Free-Float
44.94%
Yield 2024 *
-
Yield 2025 -
1 day+22.22%
1 week+4.76%
Current month-8.33%
1 month-33.33%
3 months-35.29%
6 months-53.19%
Current year-57.69%
1 week 0.02
Extreme 0.018
0.02
1 month 0.02
Extreme 0.018
0.03
Current year 0.02
Extreme 0.018
0.09
1 year 0.02
Extreme 0.018
0.09
3 years 0.01
Extreme 0.008
0.09
5 years 0.01
Extreme 0.008
0.22
10 years 0.01
Extreme 0.008
0.88
Manager TitleAgeSince
President 46 30/04/2024
Comptroller/Controller/Auditor 44 01/07/2024
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 64 14/06/2021
Director/Board Member 55 31/03/2023
Director/Board Member 70 27/11/2023
Date Insider Type Main position Quantity % Market Cap. Importance
30/4/21 Exercice

Chairman

330,000 0.1250%
19/8/20 Free

Chairman

1,130,000 0.4340%
Change 5-day change 1-year change 3-year change Capi.($)
+22.22%+4.76%-4.35%+46.67% 24.24M
-2.55%+3.32%+18.95%+55.98% 259B
-1.34%+2.57%+5.82%+17.85% 163B
-2.14%-6.11%-23.16%+58.52% 152B
-2.06%-0.99%-57.55%-14.27% 64.07B
-0.01%+4.94%+23.63%+64.77% 60.84B
-0.13%-1.90%+1.13%-7.61% 53.91B
-2.23%+0.72%+14.18%+59.50% 48.78B
-0.77%-2.48%+1.84%+83.20% 48.96B
-1.85%+2.01%+19.32%+80.60% 45.43B
Average +1.12%-2.22%-0.02%+44.52% 90B
Weighted average by Cap. -1.61%+0.60%+2.01%+44.15%

Financials

2024 2025
Net sales 858K 667K 603K 556K 504K 950K 62.67M 979K 6.68M 2.65M 33.5M 2.5M 2.45M 107M 5.26M 4.09M 3.7M 3.41M 3.09M 5.83M 384M 6M 40.96M 16.28M 205M 15.34M 15.01M 654M
Net income -3.43M -2.67M -2.41M -2.23M -2.02M -3.8M -251M -3.92M -26.73M -10.62M -134M -10.01M -9.8M -427M -3.96M -3.08M -2.78M -2.57M -2.33M -4.39M -289M -4.52M -30.84M -12.26M -155M -11.55M -11.31M -492M
Net Debt 1.46M 1.13M 1.02M 944K 854K 1.61M 106M 1.66M 11.33M 4.5M 56.82M 4.24M 4.15M 181M 1.86M 1.44M 1.3M 1.2M 1.09M 2.06M 136M 2.12M 14.45M 5.74M 72.48M 5.41M 5.3M 231M
Projected Income Statement - Annual - Embracing Future Holdings Limited
Logo Embracing Future Holdings Limited
Embracing Future Holdings Ltd, formerly Biolidics Limited, is a precision medicine medical technology company. Its principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
Employees
-
Date Price Change Volume
13/11/26 SGD 0.0220 +22.22% 2,100
12/11/26 SGD 0.0180 -10.00% 661,000
11/11/26 SGD 0.0200 -4.76% 1,100
10/11/26 SGD 0.0210 0.00% 394,000
06/11/26 SGD 0.0210 -12.50% 317,600